Search
Displaying results 1091 to 1100 of 1202.
Hope for antibody therapy against Covid-19
A team of virologists at the Helmholtz Centre for Infection Research (HZI), together with the Technische Universität (TU) Braunschweig and the biotech company YUMAB , has succeeded in identifying antibodies from their antibody libraries that neutralise the novel…
Strategies to contain the COVID-19 pandemic
In view of the great public importance of an objective evidence base regarding the occurrence of infections, our research organizations ( Fraunhofer-Gesellschaft , Helmholtz Association , Leibniz Association , Max Planck Society ) have decided to jointly state their…
LoewenKIDS help scientists in a COVID-19 study
At the end of 2014, the Helmholtz Centre for Infection Research (HZI) initiated a long-term study to assess young children with regard to developments in their immune systems and interactions with infections. The study accompanies children from time of birth up until…
Searching for drugs against SARS-CoV-2
"I am confident that within a few weeks we will find substances that can inhibit the replication of the virus. This will give us a comprehensive picture of the effectiveness of the substances against this corona virus, as the investigations in the various laboratories…
Kliniklabor bekommt Unterstützung vom HZI und der TU Braunschweig
Beide Institutionen stellen dem Klinikum Braunschweig sowohl Technik, als auch fachliches Know-How zur Verfügung. Dr. Thomas Bartkiewicz, Ärztlicher Direktor des Klinikums Braunschweig, sagt: „Durch die enorme Unterstützung können wir unsere Testkapazitäten deutlich…
To the site of action - in the nanotransporter
The world is currently fascinated by pharmaceutical research, which is supposed to free us from the burden of the new coronavirus SARS-CoV-2. In addition to the search for a vaccine, the further development of other drugs is of crucial importance, especially now and…
Inactivated viruses for vaccine development
Four projects are currently being developed to exploit the possibilities of GSI and FAIR research in the corona crisis and to expand the fundamental knowledge about the virus. The researchers are working on contributions to the development of vaccines as well as on…
Helmholtz position paper on the epidemiological situation
The HZI scientists from the departments of Systems Immunology (located at BRICS ) and Epidemiology, together with colleagues from Forschungszentrum Jülich, analyse available epidemiological data in Germany and the German federal states using mathematical models. With…
"It's too early to ease restrictions"
At present, there are increasing demands to relax the restrictions on social life that have been imposed since mid-March. So far, it has remained relatively unclear how effective the restrictions are. Scientists led by the physicist Prof Michael Meyer-Hermann, head of…
Step-by-step Plan for after the Shutdown
The strategy envisions the gradual easing of current restrictions in a differentiated way and under continuous consideration of the risks. Priority will be given to restrictions that incur high economic costs or lead to severe social and health burdens. Regions with low…
